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Abstract
Background: The initiation of the Canadian Multicentre Osteoporosis Study in 1996, and subsequent follow-up
of the cohort 5 years later, provided longitudinal body mass index (BMI) data for a random sample of Canadians.
Methods: Height and weight were measured at baseline and 5 years and used to calculate BMI and assign one of
six weight categories. Multiple imputation was used to adjust for missing weight at year 5. Data were stratified by
age and gender. The proportion of participants moving between categories was generated, and multivariable linear
regression was used to identify factors associated with weight change.
Results: Baseline data were available for 8548 participants, year 5 data for 6721, and year 5 weight was imputed
for 1827 (17.6%). Mean BMI for every age and gender group exceeded healthy weight guidelines. Most remained
within their BMI classification over 5 years, but when change occurred, BMI category was more likely to increase
than decrease. Several sociodemographic, lifestyle and clinical characteristics were associated with change.
Conclusion: Mean baseline BMI tended to be higher than recommended. Moreover, on average, men under age
45 and women under age 55 were gaining approximately 0.45 kilograms (one pound) per year, which leveled off
with increased age and reversed in the oldest age groups. These findings underscore the need for public health
efforts aimed at combating obesity.
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The World Health Organization has recommended an
updated classification system for the assessment of body
mass index (BMI, defined as weight in kilograms divided
by height in meters squared) in adults [1]. This system
defines underweight as a BMI of < 18.5, normal as 18.5–
24.99, overweight as 25.0–29.99, and includes three
classes of obesity for those with a BMI of 30.0–34.99,
35.0–39.99, and ≥ 40.0 [1,2]. Given this new classifica-
tion, it is helpful to understand changes in BMI over time
in the general population.
It is widely accepted that given a certain height, there is a
range of weight that is associated with good general health
[2,3]. Despite this knowledge, there is evidence that the
prevalence of being overweight or obese is reaching epi-
demic proportions across all age groups, both in devel-
oped and developing countries [2,4-11]. The most recent
US data based on measured height and weight found that
65.1% of adults over 18 years were overweight [9]. Cana-
dian data based on measured heights and weights found
that 65% of men and 53% of women over 18 years were
overweight or obese [12], suggesting that the overall US
rate is somewhat higher than that of Canadians [9].
Being overweight or obese can have a significant impact
on health, as these individuals are more likely to suffer
from a variety of illnesses [1,2,10,11,13], have an
increased risk of mortality [14-16], and use more health
care resources and disability days [11] than their normal
weight peers. In 2000, the cost of obesity in the US was
estimated at $117 billion dollars [17], while the Canadian
estimate for 2001 was $4.3 billion US [18]. Being under-
weight is also associated with a number of health risks
[2,3,19] and an increased risk of mortality [14,16],
although considerably less work has gone into assessment
of underweight as compared to overweight individuals
[2,3].
Few longitudinal studies have assessed changes in BMI
over time. Data with measurements at two-year intervals
from the Framingham Heart Study suggest that BMI tends
to be stable over time [20]. The Canada Fitness Survey,
which had an upper age limit of 69 years at baseline,
found that weights tended to be reasonably stable over 7
years [21], although all mean seven-year changes were in
an upward direction. However, data from the National
Population Health Survey (Statistics Canada), with 8
years of follow-up of self-reported BMI, suggest that 32%
of those whose weight was normal at baseline became
overweight, and that almost a quarter of those who had
been overweight became obese, while only 10% of those
who were overweight dropped to the normal category
[22].
There is a need for a population-based study of measured
BMI in order to examine longitudinal weight change
[5,7,13]. The initiation of the Canadian Multicentre Oste-
oporosis Study (CaMos) in 1996, and subsequent follow-
up of the cohort 5 years later, provided this opportunity.
CaMos is not a study of individuals with osteoporosis;
rather, it was designed to study the incidence and preva-
lence of osteoporosis in a random sample of Canadians
25 years of age and older [23]. This allowed us to examine
the number of participants in each of the weight catego-
ries at baseline and 5 years, stratified by age and gender,
to determine if BMI is increasing and if so, which age and
sex groups are at greatest risk.
Methods
CaMos is an on-going, prospective cohort study of 9,423
non-institutionalized, randomly selected men and
women aged 25 years and older at baseline, drawn from a
50-kilometer radius of nine Canadian cities (St John's,
Halifax, Quebec City, Toronto, Hamilton, Kingston, Sas-
katoon, Calgary and Vancouver). Baseline assessments
took place between February 1996 and September 1997,
and the 5-year follow-up took place between February
2001 and September 2002. All data were obtained by
trained interviewers, who used a questionnaire with good
reproducibility that was designed for the CaMos study.
Participants provided written consent.
A detailed description of the objectives, methodology and
sampling framework for CaMos is available elsewhere
[23]. Briefly, households within each region were selected
by random draws of listed telephone numbers, and one
randomly selected household member 25 years of age or
older was asked to participate. Of 22,173 eligible house-
holds, 27.5% declined to participate, 30.0% completed a
short questionnaire that provided information about the
age, gender and fracture history of the residents, and
9,423 (42.5%) went on to participate fully in the study.
CaMos was designed to collect epidemiological data
related to the incidence and prevalence of osteoporosis, so
although the sampling framework was random, it was
designed to include more women than men, and a higher
number of older than younger Canadian residents.
Ethics approval was obtained through the Review Boards
of each participating centre. These included Memorial
University of Newfoundland Human Investigation Com-
mittee (St John's), the Capital Health Research Ethics
Board (Halifax), Comité d'éthique de la recherché cli-
nique du Centre Hopitalier Universitaire de Québec
(Quebec City), St. Michael's Hospital Research Ethics
Board (Toronto), McMaster University Research Ethics
Board (Hamilton), Queen's University Health Sciences
and Affiliated Teaching Hospitals Research Ethics Board
(Kingston), University of Saskatchewan BiomedicalPage 2 of 11
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Health Research Ethics Board (Calgary), University of Brit-
ish Columbia Clinical Research Ethics Board (Vancouver)
and the McGill University Health Centre Research Ethics
Committee (Montreal).
The majority of participants were scheduled for dual-
energy x-ray absorptiometry (DXA) assessment of bone
mineral density (BMD) as part of the study protocol, at
which time both height and weight were measured.
Height was measured without shoes, using a wall-
mounted stadiometer, ruler on the wall or a measure on a
weight scale. Weight was measured in light clothing using
a beam balance or electronic scale. For those who elected
not to have the DXA, or for whom it could not be sched-
uled, the interviewer measured height and weight with a
carpenter's rule and a portable scale. Baseline height and
weight were used to calculate the baseline BMI. Five-year
BMI was calculated using the baseline height and the
weight at year 5. Baseline height was used to avoid the
need to impute height for those missing height at year 5,
as the loss of height over time was expected to be close to
zero for the majority of participants. Change in BMI was
calculated as year 5 minus the baseline value, so that pos-
itive values would indicate an increase in weight.
Multivariable linear regression was used to identify the
factors associated with five year changes in BMI for men
and women. Variables were identified on the basis of an
extensive literature review, and included sociodemo-
graphic characteristics (age, region of Canada, education,
annual household income, whether they lived alone and
employment status), clinical characteristics (menopausal
status, parity, a variety of individual comorbid conditions,
and number of comorbid conditions), and other factors
(smoking, alcohol use, hours spent walking, hours spent
sitting, participation in regular activities, level of pain,
level of happiness and perception of general health). In
addition, since we expected that changes in some of these
variables could be associated with changes in BMI, change
variables were also examined for menopausal status,
comorbidities, smoking, alcohol use, the activity varia-
bles, level of pain, level of happiness, and perception of
general health.
Univariate associations between all variables and change
in BMI were examined to refine the list of predictors iden-
tified above, removing any for which there was no evi-
dence to support its inclusion. For some, the 95%
confidence interval (CI) may have included zero but if
one or both of the upper or lower limits could be of clin-
ical interest, the variable was retained, allowing the inves-
tigators to see the effects of all variables of potential
interest. Three variables not automatically retained in the
model by these a priori considerations (menopausal sta-
tus, parity and alcohol consumption) were retained due to
widespread belief that the variable was associated with
weight change [22,24-26].
Not all participants who provided baseline data partici-
pated at year 5, and differences in the characteristics
between participants and non-participants could cause
the estimates to be biased. For example, this could occur
if subjects with certain diseases tended to lose weight or
not participate because they were unwell. Multiple impu-
tation [27] was therefore used to at least partially adjust
for possible selection bias for all surviving participants
who did not provide 5-year data. In addition, those who
were pregnant at baseline or year 5 were excluded from
the analysis, as were those who did not have height and/
or weight recorded at baseline.
Within the multiple imputation models, linear regression
models were fit to predict weight at year 5, using data from
respondents with complete data at both time points.
Models included baseline height and weight, age, and
BMD of the femoral neck from year 5 if available, other-
wise at baseline. Separate models were developed for men
and women within each age group. Covariate data from
those missing year 5 weights were then entered into the
models to impute the missing weights. Simultaneous
regression parameter estimations and multiple imputa-
tions were carried out via a Gibbs sampler algorithm as
implemented in WinBugs software (version 1.4, Cam-
bridge, Institute of Public Health, MRC Biostatistics Unit,
2004).
Results
Complete baseline data were available for 2572 men and
5976 women, for a total of 8548 (90.7% of the original
cohort). Height and/or weight were missing for 277 at
baseline, primarily due to scheduling difficulties for the
DXA at two sites. Six were pregnant at baseline or at fol-
low-up. Six hundred and forty-four had died by the time
of the 5-year follow-up, and although 592 of these had
provided baseline data (52 of those who died were also
missing the baseline measurements), their data were not
used since 5-year BMI changes were undefined for these
subjects.
At year 5, data were available for 1959 (76.2%) men and
4762 (79.7%) women, for a total of 6721, and were
imputed for 1827 (613 men and 1214 women). Of these
1827, 764 were still in the cohort but were missing weight
at year 5, largely due to scheduling difficulties and one site
that had not measured weight at the time of the DXA.
Another 415 completed a short questionnaire over the tel-
ephone. The reasons for loss to follow-up included 265
who could not be contacted, 106 who withdrew consent,
89 who were too sick, 114 who had moved away, and 74Page 3 of 11
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no reason given.
Those without complete year 5 were represented in all cat-
egories of weight. For men, 33.3% of those in the under-
weight group and 35.0% of those in the obese class III
group at baseline were missing year 5 data. For other
weight categories, the proportions with incomplete year 5
data ranged from 21.4% (overweight) to 26.3% (obese
class I). Among women, the proportions with incomplete
data ranged from 19.1% of those in the normal weight
category to 27.8% of those in obese class III. For the other
categories, the proportions were very similar, ranging
from 20.5% (overweight) to 21.8 (obese class II), suggest-
ing that there was no bias due to greater loss to follow-up
within certain weight categories.
Figure 1 contains the mean baseline BMI for men and
women across 10-year age stratifications, along with the
associated 95% confidence intervals (CI). The mean BMI
for every age group for both genders exceeded the healthy
weight guidelines of BMI below 251,2. The lower limit of
the 95% CI was less than 25 for only one group (women
25–34 years), and was exactly 25.0 for women aged 35–
44 years. This figure also contains the mean 5-year change
in BMI with the 95% CI for the age and gender groups.
The increases in BMI were much larger for men between
25 and 44 years and women between 25 and 54 years than
in the older groups, in which the BMI tended to decrease.
Tables 1 (men) and 2 (women) contain the weight classi-
fications at baseline by age group, along with the Year 5
values (actual and imputed). For men, with the exception
of the baseline weight for the 25–34 year age group and
the Year 5 observed and imputation adjusted values for
the 75+ age group, the majority of values fell into the over-
weight category. For women, the majority of values were
in the normal category for the two youngest groups and
the 75+ age group. For those aged 45–74 years, the per-
centages in the normal weight and overweight categories
were very close. A small majority of those in the 45–54
year age group were in the normal weight category, while
an equally small majority of those aged 55–74 years were
in the overweight category.
Tables 3 (men) and 4 (women) contain the percentages
staying within a certain BMI category or moving into
another group, by age. For example, a man in his early
40's and of normal weight at baseline has a 62.7% chance
of staying within his weight category, a 0.5% chance of
dropping into the underweight category and a 34.4%
chance of moving into the overweight category after 5
years. The largest probabilities are within the same weight
category at baseline and at year 5, suggesting that people
Table 1: Weight classification at baseline and year five (including imputed) for men. Values are expressed as frequencies and percent of 
age group total
Baseline Age Time Sample Size* Underweight Normal Weight Overweight Obese Class I Obese Class II Obese Class III
25 – 34 Baseline
Year 5
187
187
2 (1.1)
1 (0.5)
85 (45.5)
70 (37.4)
78 (41.7)
82 (43.9)
18 (9.3)
25 (13.4)
3 (1.6)
7 (3.7)
1 (0.5)
2 (1.1)
35 – 44 Baseline
Year 5
205
205
2 (1.0)
1 (0.5)
70 (34.2)
53 (25.9)
97 (47.3)
106 (51.7)
28 (13.7)
34 (16.6)
5 (2.4)
6 (2.9)
3 (1.5)
5 (2.4)
45 – 54 Baseline
Year 5
564
565
1 (0.2)
3 (0.5)
157 (27.8)
145 (25.7)
288 (51.1)
277 (49.0)
89 (15.8)
104 (18.4)
25 (4.4)
31 (5.5)
4 (0.7)
5 (0.9)
55 – 64 Baseline
Year 5
609
608
2 (0.3)
2 (0.3)
135 (22.2)
132 (21.7)
317 (52.1)
308 (50.7)
125 (20.5)
129 (21.2)
26 (4.3)
33 (5.4)
4 (0.7)
4(0.7)
65 – 74 Baseline
Year 5
705
705
3 (0.4)
3 (0.4)
197 (27.9)
220 (31.2)
361 (51.2)
344 (48.8)
127 (18.0)
117 (16.6)
11 (1.6)
17 (2.4)
6 (0.9)
4 (0.6)
75 + Baseline
Year 5
302
302
2 (0.7)
6 (2.0)
117 (38.7)
137 (45.4)
143 (47.4)
116 (38.4)
32 (10.6)
36 (11.9)
6 (2.0)
5 (1.7)
2 (0.7)
2 (0.7)
* Baseline and year 5 values are not always identical due to rounding in the imputation process.
Underweight = BMI<18; Normal weight = BMI 18.5–24.99; Overweight = BMI 25.0–29.99; Obese Class I = BMI 30.0–34.99; Obese Class II = BMI 
35.0–39.99; Obese Class III = BMI ≥ 40.0
Baseline body mass index (BMI) and 5-year change in BMI, by age group and genderFigu e 1
Baseline body mass index (BMI) and 5-year change in 
BMI, by age group and gender. Numbers on the left axis 
represent body mass index (BMI). Solid squares represent 
the mean baseline BMI, and the error bars represent the 95% 
confidence interval (CI). Numbers on the right axis represent 
mean change in BMI. Open triangles represent the mean 5-
year change in BMI, and the error bars represent the 95% CI.
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The major exceptions to this are in underweight men in
most age groups (Table 3), where weight gain into the
normal range generally occurred. Furthermore, in general,
the data suggest that if there is a change, there is a far
greater probability of increasing by a category compared
to decreasing by a category in the younger age groups; this
reverses for the older age groups and at higher levels of
weight.
The results of movement from one BMI category to
another over 5 years are very similar for women (Table 4).
A woman in her early 40's with a normal baseline weight
has an 82.7% chance of staying in that category, a 2.1%
chance of dropping into the underweight group and a
13.6% chance of moving into the overweight category.
However, with increasing age and/or for those in higher
BMI categories, there is an increased likelihood of drop-
ping by a category relative to increasing by a category.
Table 5 contains the results of the regression modeling.
Thirteen variables were retained in the model for women,
while 11 were retained for men. Eight of these (7 for men)
were measured at baseline and 5 (4 for men) were based
on change between baseline and follow-up. The models
accounted for just under 9% of the total variation in out-
come, so much of the variance is unexplained by our cov-
ariates. In general, variables associated with an increase in
weight included household income greater than $20,000,
and education levels lower than a university degree. All
regions of Canada were associated with less gain, as com-
pared to the reference category (Saskatoon, representing
Central Canada). All age categories for both genders were
associated with weight gain when compared to the refer-
ence category of age 75+, as already demonstrated in Fig-
ure 1.
Current smokers and those who had never smoked tended
to gain less weight as compared to those who had quit
smoking, although only one of the four comparisons
attained clinical importance in that the 95% CI did not
include zero. Higher alcohol consumption was associated
with small declines for both men and women, but the
results were inconclusive for both. Those who felt less
happy or whose happiness assessment stayed about the
same, also saw less gain as compared to those who indi-
cated that their level of happiness had improved,
although this result was inconclusive for men. Some cate-
gories of changes in participation in regular activity,
change in number of sedentary hours, and perception of
overall health were also associated with increases in BMI
for either men or women, although not always in the
expected direction. For example, those who indicated that
their number of sedentary hours was quite low still saw a
small increase in the parameter estimates.
For women, the association between number of live births
and weight change was virtually non-existent. Finally,
after adjusting for age, the effect of menopause was also
inconclusive, although it is of clinical interest that those
who had not yet become menopausal, or who had
become menopausal recently, saw small declines as com-
pared to those who were already menopausal at baseline.
Discussion
These results add to the growing body of literature sug-
gesting that the prevalence of overweight and obesity is
increasing. The mean baseline BMI exceeded 25.0 for
every age and gender category studied, ranging from 25.6
(women aged 35–44) to 27.7 (men aged 55–64). The
mean change over 5 years does not appear large at face
value, ranging from an increase of 1.07 for the youngest
group of men to a drop of 0.96 for the oldest group of
Table 2: Weight classification at baseline and year five (including imputed) for women. Values are expressed as frequencies and 
percent of age group total
Baseline Age Time Sample Size* Underweight Normal Weight Overweight Obese Class I Obese Class II Obese Class III
25 – 34 Baseline
Year 5
187
188
5 (2.7)
4 (2.1)
101 (54.0)
84 (44.7)
50 (26.7)
56 (29.8)
15 (8.0)
25 (13.3)
10 (5.4)
11 (5.9)
6 (3.2)
8 (4.3)
35 – 44 Baseline
Year 5
278
277
3 (1.1)
3 (1.1)
155 (55.8)
140 (50.5)
70 (25.2)
66 (23.8)
34 (12.2)
44 (15.9)
7 (2.5)
16 (5.8)
9 (3.2)
8 (2.9)
45 – 54 Baseline
Year 5
1082
1083
10 (0.9)
12 (1.1)
433 (40.0)
382 (35.3)
377 (34.8)
382 (35.3)
158 (14.6)
189 (17.5)
81 (7.5)
79 (7.3)
23 (2.1)
39 (3.6)
55 – 64 Baseline
Year 5
1564
1562
19 (1.2)
28 (1.8)
526 (33.6)
469 (30.0)
629 (40.2)
623 (39.9)
269 (17.2)
315 (20.2)
87 (5.6)
92 (5.9)
34 (2.2)
35 (2.2)
65 – 74 Baseline
Year 5
1945
1940
37 (1.9)
56 (2.9)
680 (35.0)
692 (35.7)
735 (37.8)
713 (36.8)
362 (18.6)
352 (18.1)
99 (5.1)
99 (5.1)
32 (1.7)
28 (1.4)
75 + Baseline
Year 5
920
918
24 (2.6)
49 (5.3)
367 (39.9)
414 (45.1)
351 (38.2)
317 (34.5)
142 (15.4)
113 (12.3)
32 (3.5)
22 (2.4)
4 (0.4)
3 (0.3)
* Baseline and year 5 values are not always identical due to rounding in the imputation process.
Underweight = BMI<18; Normal weight = BMI 18.5–24.99; Overweight = BMI 25.0–29.99; Obese Class I = BMI 30.0–34.99; Obese Class II = BMI 
35.0–39.99; Obese Class III = BMI ≥ 40.0Page 5 of 11
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mean baseline value, all values remain greater than 25,
and the values increase for all but the two oldest age
groups, for both men and women. In view of the fact that
the mean BMI exceeded 25 even in the youngest age
groups in both men and women (Figure 1), it seems likely
that excess weight gain has its inception before age 25.
Weight regulation depends on a balance between energy
intake via food and energy expenditure. Evolving knowl-
edge indicates that complex neuronal and hormonal
input to the hypothalamus and brain stem controls food
intake, and peripheral circulating adipostat factors and
gut hormones are highly important in appetite control
and food intake regulation [28]. The results presented in
Tables 1 and 2 suggest that the number within the BMI
categories remains relatively stable despite the trend
towards small annual increases as seen in Figure 1, which
is consistent with previous research [20,21] and the well-
developed homeostatic role for weight regulation [28].
The results in Tables 3 and 4 suggest that the highest per-
centage of those studied will remain within their original
Table 3: Percentage of men staying within baseline weight category versus switching to another category
Age at 
baseline
(years)
Category at 
Baseline
Underweight At 
Year 5 (95% CI)
Normal Weight At 
Year 5 (95% CI)
Overweight At 
Year 5 (95% CI)
Obese Class I At 
Year 5 (95% CI)
Obese Class II At 
year 5 (95% CI)
Obese Class III At 
Year 5 (95% CI)
25 – 34 Underweight 21.2 (0.0–77.3) 60.5 (8.6–100.0) 3.9 (0.0–25.0) 3.6 (0.0–22.1) 3.4 (0.0–21.8) 7.4 (0.0–39.3)
Normal Weight 1.2 (0.0–4.5) 67.9 (57.0–78.7) 30.3 (19.9–41.0) 0.2 (0.0–1.3) 0.1 (0.0–0.6) 0.2 (0.0–1.2)
Overweight 0.1 (0.0–0.7) 13.1 (5.8–21.4) 71.1 (59.4–82.2) 15.2 (6.3–24.5) 0.2 (0.0–1.4) 0.2 (0.0–1.3)
Obese Class I 0.5 (0.0–3.1) 0.5 (0.0–3.3) 3.5 (0.0–15.6) 68.2 (44.0–90.7) 26.0 (5.2–48.3) 1.2 (0.0–6.2)
Obese Class II 2.6 (0.0–16.2) 2.7 (0.0–16.3) 2.7 (0.0–17.1) 5.9 (0.0–36.6) 50.2 (5.8–94.9) 35.9 (0.1–80.0)
Obese Class III 5.8 (0.0–37.5) 5.7 (0.0–36.6) 6.0 (0.0–39.8) 5.8 (0.0–38.4) 6.1 (0.0–38.5) 70.6 (14.4–100.0)
35 – 44 Underweight 18.1 (0.0–74.9) 62.9 (9.5–100.0) 4.2 (0.0–27.2) 3.7 (0.0–24.1) 3.7 (0.0–23.1) 7.3 (0.0–37.1)
Normal Weight 0.5 (0.0–2.8) 62.7 (49.6–76.5) 34.4 (21.3–47.9) 0.6 (0.0–3.0) 1.6 (0.0–4.5) 0.3 (0.0–1.5)
Overweight 0.1 (0.0–0.6) 7.3 (2.0–13.5) 79.1 (69.6–87.9) 13.0 (6.0–20.9) 0.2 (0.0–1.0) 0.2 (0.0–1.1)
Obese Class I 0.3 (0.0–2.1) 0.4 (0.0–2.4) 17.2 (3.5–32.9) 73.1 (54.2–90.7) 8.3 (0.0–20.0) 0.7 (0.0–3.7)
Obese Class II 1.8 (0.0–11.0) 1.8 (0.0–10.8) 1.8 (0.0–10.7) 2.3 (0.0–14.3) 49.3 (11.3–87.8) 43.0 (6.3–81.1)
Obese Class III 2.6 (0.0–16.5) 2.7 (0.0–16.7) 2.9 (0.0–17.9) 2.7 (0.0–16.9) 8.1 (0.0–46.4) 81.0 (37.0–100.0)
45 – 54 Underweight 36.3 (0.0–98.2) 34.3 (0.0–98.1) 5.9 (0.0–38.7) 5.7 (0.0–37.6) 6.0 (0.0–38.3) 11.8 (0.0–58.1)
Normal Weight 1.4 (0.0–3.5) 73.9 (66.1–81.4) 23.9 (16.7–31.5) 0.7 (0.0–2.1) 0.1 (0.0–0.4) 0.1 (0.0–0.6)
Overweight 0.0 (0.0–0.2) 9.9 (6.1–13.7) 76.6 (71.4–82.0) 13.0 (8.8–17.2) 0.4 (0.0–1.1) 0.1 (0.0–0.4)
Obese Class I 0.1 (0.0–0.7) 0.1 (0.0–0.7) 19.8 (11.5–29.4) 68.7 (57.9–79.1) 11.1 (4.4–18.3) 0.2 (0.0–1.1)
Obese Class II 0.4 (0.0–2.3) 0.4 (0.0–2.3) 4.3 (0.0–12.1) 12.4 (0.7–26.1) 72.1 (53.9–90.3) 10.4 (0.9–23.0)
Obese Class III 2.1 (0.0–13.4) 2.1 (0.0–13.2) 2.1 (0.0–13.3) 2.2 (0.0–13.6) 34.5 (0.0–77.3) 56.9 (15.4–99.0)
55 – 64 Underweight 40.7 (0.3–85.2) 40.9 (0.1–85.6) 3.8 (0.0–23.8) 3.7 (0.0–23.2) 3.6 (0.0–23.2) 7.4 (0.0–39.3)
Normal Weight 0.2 (0.0–1.4) 74.0 (66.2–81.6) 24.7 (17.4–32.6) 0.9 (0.0–2.5) 0.1 (0.0–0.5) 0.2 (0.0–0.8)
Overweight 0.0 (0.0–0.2) 9.7 (6.3–13.5) 78.0 (72.9–82.9) 12.2 (8.4–16.1) 0.0 (0.0–0.3) 0.1 (0.0–0.3)
Obese Class I 0.9 (0.0–2.5) 0.1 (0.0–0.6) 21.5 (13.6–29.5) 67.1 (58.0–76.1) 10.3 (5.0–16.4) 0.2 (0.0–0.9)
Obese Class II 0.4 (0.0–2.3) 0.4 (0.0–2.2) 0.5 (0.0–2.6) 16.0 (2.8–30.5) 72.8 (54.4–89.5) 10.0 (0.6–21.7)
Obese Class III 2.2 (0.0–13.4) 2.1 (0.0–12.8) 2.1 (0.0–12.7) 23.8 (0.0–59.2) 29.3 (0.0–76.9) 40.5 (0.0–85.5)
65 – 74 Underweight 29.6 (0.0–69.7) 57.1 (16.4–96.5) 2.5 (0.0–15.7) 2.8 (0.0–17.1) 2.6 (0.0–16.4) 5.4 (0.0–27.6)
Normal Weight 0.5 (0.0–1.8) 86.2 (80.7–91.5) 13.1 (8.0–18.5) 0.1 (0.0–0.4) 0.1 (0.0–0.3) 0.1 (0.0–0.5)
Overweight 0.3 (0.0–0.9) 13.1 (9.3–16.8) 80.1 (75.4–84.4) 6.5 (3.7–9.2) 0.0 (0.0–0.2) 0.1 (0.0–0.3)
Obese Class I 0.1 (0.0–0.5) 0.9 (0.0–2.6) 21.3 (13.8–29.4) 71.3 (62.5–79.7) 6.2 (2.2–11.0) 0.2 (0.0–0.8)
Obese Class II 0.8 (0.0–5.0) 0.9 (0.0–5.0) 9.5 (0.0–26.1) 24.2 (2.3–49.6) 62.3 (34.8–90.6) 2.3 (0.0–12.2)
Obese Class III 1.5 (0.0–8.6) 1.5 (0.0–9.2) 1.5 (0.0–9.4) 1.5 (0.0–8.7) 31.4 (3.0–63.4) 62.7 (29.2–93.9)
75 + Underweight 62.6 (9.0–100.0) 18.8 (0.0–74.9) 3.8 (0.0–23.6) 3.6 (0.0–22.9) 3.8 (0.0–23.4) 7.4 (0.0–38.4)
Normal Weight 4.0 (0.2–8.5) 87.3 (80.0–94.3) 7.5 (2.2–13.4) 0.9 (0.0–2.6) 0.1 (0.0–0.5) 0.2 (0.0–0.9)
Overweight 0.1 (0.0–0.4) 24.3 (16.5–32.3) 68.7 (60.0–77.0) 6.7 (2.4–11.3) 0.1 (0.0–0.4) 0.1 (0.0–0.8)
Obese Class I 0.3 (0.0–1.7) 0.4 (0.0–2.2) 23.2 (7.6–38.6) 70.1 (52.6–86.6) 5.4 (0.0–14.4) 0.6 (0.0–3.2)
Obese Class II 1.5 (0.0–9.1) 1.5 (0.0–8.8) 16.5 (0.0–43.2) 35.5 (0.1–74.4) 40.5 (0.0–78.0) 4.5 (0.0–23.1)
Obese Class III 3.7 (0.0–23.7) 3.5 (0.0–22.5) 3.8 (0.0–24.3) 3.7 (0.0–23.7) 18.2 (0.0–74.8) 67.0 (12.2–100.0)
CI = Confidence IntervalPage 6 of 11
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initially underweight was there a tendency to increase BMI
into the normal range. This observation may be consistent
with the thesis that the complex neurohormonal regula-
tion of weight regulation may have evolved primarily to
prevent starvation [28].
In considering the relative stability of the weight catego-
ries despite evidence of increasing weight over time, one
must bear in mind that a person can stay within their
weight category despite a significant weight gain. For
example, a woman at the average Canadian height of 163
centimetres (cm) would weigh 49.1 kg for a BMI of 18.50
and 66.3 kg for a BMI of 25.0, representing an increase of
17.2 kg (37.9 pounds) to move into the overweight cate-
gory if starting at the lowest point in the normal weight
category. To do the same, a man at the average Canadian
height of 178 cm would weigh 58.5 kg for a BMI of 18.50
and 79.1 kg for a BMI of 25.0, representing an increase of
20.6 kg (45.4 pounds). In these two examples, to move up
by one BMI point, the woman would have to gain 2.6 kg
(5.7 pounds), while the man would have to gain 3.1 kg
Table 4: Percentage of women staying within baseline weight category versus switching to another category
Age at 
baseline
(years)
Category at 
Baseline
Underweight At 
Year 5 (95% CI)
Normal Weight At 
Year 5 (95% CI)
Overweight At 
Year 5 (95% CI)
Obese Class I At 
Year 5 (95% CI)
Obese Class II At 
year 5 (95% CI)
Obese Class III At 
Year 5 (95% CI)
25 – 34 Underweight 54.4 (18.1–89.8) 36.8 (3.4–72.2) 1.7 (0.0–10.4) 1.8 (0.0–11.3) 1.8 (0.0–10.7) 3.5 (0.0–18.2)
Normal Weight 1.0 (0.0–3.7) 75.5 (65.9–84.4) 22.8 (13.7–31.8) 0.4 (0.0–2.0) 0.1 (0.0–0.5) 0.2 (0.0–1.0)
Overweight 0.2 (0.0–1.1) 10.5 (2.6–19.7) 56.9 (41.5–71.4) 29.5 (16.2–43.2) 2.5 (0.0–7.0) 0.4 (0.0–2.0)
Obese Class I 0.6 (0.0–3.5) 0.7 (0.0–4.2) 24.5 (4.5–47.1) 51.6 (24.9–75.8) 8.6 (0.0–23.7) 14.0 (0.7–30.7)
Obese Class II 0.9 (0.0–5.5) 1.0 (0.0–5.9) 1.0 (0.0–5.6) 14.6 (0.0–37.7) 57.7 (29.0–88.6) 24.8 (1.8–50.2)
Obese Class III 1.5 (0.0–9.2) 1.5 (0.0–9.1) 1.5 (0.0–9.0) 1.6 (0.0–9.3) 34.5 (3.1–68.5) 59.3 (23.8–92.3)
35 – 44 Underweight 2.5 (0.0–15.5) 84.1 (48.6–100.0) 2.6 (0.0–15.4) 2.7 (0.0–16.5) 2.7 (0.0–16.9) 5.4 (0.0–28.3)
Normal Weight 2.1 (0.1–4.6) 82.7 (76.3–89.1) 13.6 (7.8–19.3) 1.4 (0.1–3.4) 0.1 (0.0–0.4) 0.1 (0.0–0.7)
Overweight 0.2 (0.0–0.9) 12.5 (4.6–21.4) 58.3 (45.2–70.6) 28.5 (17.8–40.4) 0.3 (0.0–1.9) 0.3 (0.0–1.6)
Obese Class I 0.3 (0.0–1.6) 0.3 (0.0–2.1) 12.5 (2.1–24.9) 59.8 (42.0–77.6) 26.2 (10.9–42.8) 0.9 (0.0–4.5)
Obese Class II 1.3 (0.0–7.6) 1.4 (0.0–8.3) 1.4 (0.0–8.0) 20.9 (0.0–52.3) 58.9 (22.4–96.4) 16.3 (0.0–47.8)
Obese Class III 1.0 (0.0–5.8) 1.0 (0.0–5.9) 1.1 (0.0–6.5) 1.0 (0.0–6.3) 24.3 (0.9–50.3) 71.6 (43.4–96.5)
45 – 54 Underweight 56.9 (28.8–84.3) 38.5 (12.3–65.9) 0.9 (0.0–5.6) 1.0 (0.0–6.1) 0.9 (0.0–5.1) 1.9 (0.0–9.9)
Normal Weight 1.4 (0.3–2.7) 78.7 (74.5–82.8) 19.3 (15.3–23.1) 0.6 (0.0–1.3) 0.0 (0.0–0.1) 0.0 (0.0–0.2)
Overweight 0.0 (0.0–0.2) 9.7 (6.6–13.2) 68.2 (62.8–73.2) 20.7 (16.4–25.3) 1.4 (0.4–2.7) 0.1 (0.0–0.3)
Obese Class I 0.1 (0.0–0.4) 0.7 (0.0–2.1) 21.3 (14.5–28.4) 61.3 (53.2–69.5) 15.8 (9.7–22.0) 0.8 (0.0–2.2)
Obese Class II 0.1 (0.0–0.7) 0.1 (0.0–0.7) 7.5 (2.6–13.4) 14.4 (6.4–22.8) 54.7 (43.0–65.7) 23.1 (14.0–32.6)
Obese Class III 0.4 (0.0–2.6) 0.4 (0.0–2.4) 0.4 (0.0–2.6) 0.6 (0.0–3.7) 17.8 (1.8–35.4) 80.4 (62.3–96.8)
55 – 64 Underweight 51.2 (28.4–74.2) 46.3 (23.5–68.9) 0.5 (0.0–3.0) 0.5 (0.0–2.9) 0.5 (0.0–3.1) 1.0 (0.0–5.3)
Normal Weight 3.0 (1.5–4.7) 73.9 (69.8–77.7) 22.4 (18.7–26.2) 0.6 (0.1–1.4) 0.0 (0.0–0.1) 0.0 (0.0–0.2)
Overweight 0.3 (0.0–0.8) 11.1 (8.4–13.8) 71.5 (67.6–75.3) 16.9 (13.9–20.2) 0.2 (0.0–0.6) 0.0 (0.0–0.2)
Obese Class I 0.0 (0.0–0.2) 0.8 (0.0–1.9) 19.5 (14.5–24.7) 68.1 (62.0–74.1) 10.7 (6.8–14.9) 0.8 (0.0–1.9)
Obese Class II 0.1 (0.0–0.7) 1.2 (0.0–3.7) 2.5 (0.1–5.8) 23.4 (14.3–33.5) 59.1 (47.8–70.0) 13.6 (6.3–21.2)
Obese Class III 0.3 (0.0–1.6) 0.3 (0.0–1.7) 0.3 (0.0–1.7) 6.1 (0.4–14.1) 31.0 (15.7–46.6) 62.0 (45.3–77.5)
65 – 74 Underweight 73.2 (58.8–87.6) 25.5 (12.2–40.7) 0.3 (0.0–1.6) 0.3 (0.0–1.6) 0.3 (0.0–1.6) 0.5 (0.0–2.7)
Normal Weight 3.8 (2.2–5.4) 82.1 (78.9–85.2) 13.3 (10.6–16.1) 0.6 (0.1–1.3) 0.2 (0.0–0.5) 0.0 (0.0–0.2)
Overweight 0.4 (0.0–0.9) 16.7 (13.8–19.5) 73.1 (69.5–76.6) 9.5 (7.1–11.8) 0.3 (0.0–0.7) 0.0 (0.0–0.1)
Obese Class I 0.0 (0.0–0.2) 1.2 (0.2–2.3) 21.8 (17.3–26.6) 69.6 (64.5–74.7) 6.7 (4.1–9.6) 0.6 (0.0–1.4)
Obese Class II 0.1 (0.0–0.6) 0.1 (0.0–0.5) 7.2 (2.5–12.1) 26.4 (16.8–35.5) 61.9 (51.0–71.6) 4.3 (0.7–8.8)
Obese Class III 0.3 (0.0–1.8) 0.3 (0.0–2.0) 0.3 (0.0–1.9) 0.5 (0.0–2.9) 30.6 (14.3–47.4) 68.0 (50.5–83.9)
75 + Underweight 76.4 (55.5–94.3) 21.6 (2.9–40.8) 0.4 (0.0–2.6) 0.4 (0.0–2.2) 0.4 (0.0–2.6) 0.8 (0.0–4.2)
Normal Weight 8.2 (5.1–11.7) 82.0 (77.4–86.5) 9.6 (6.4–13.1) 0.1 (0.0–0.5) 0.0 (0.0–0.2) 0.1 (0.0–0.3)
Overweight 0.1 (0.0–0.4) 29.9 (24.3–35.2) 63.1 (57.2–68.8) 6.8 (4.1–9.7) 0.0 (0.0–0.2) 0.1 (0.0–0.3)
Obese Class I 0.1 (0.0–0.4) 2.1 (0.1–4.8) 41.1 (31.7–49.8) 53.8 (44.6–63.0) 2.7 (0.4–5.7) 0.1 (0.0–0.7)
Obese Class II 0.3 (0.0–1.9) 0.3 (0.0–1.7) 7.1 (0.4–16.4) 39.7 (21.9–59.1) 50.8 (32.2–70.1) 1.8 (0.0–8.0)
Obese Class III 2.1 (0.0–12.2) 2.2 (0.0–13.2) 2.1 (0.0–12.7) 3.4 (0.0–21.3) 27.0 (0.0–70.9) 63.3 (20.2–100.0)
CI = Confidence IntervalPage 7 of 11
(page number not for citation purposes)
BMC Public Health 2007, 7:150 http://www.biomedcentral.com/1471-2458/7/150Table 5: Multivariable linear regression models for change in BMI for women and men
Variable Women Parameter Estimates and 95% Confidence 
Intervals
Men Parameter Estimates and 95% Confidence 
Intervals
Intercept 3.6 (2.8, 4.3) 1.2 (0.5, 2.0)
Region of Canada (Reference = Central)
East -0.82 (-1.09, -0.55) -0.66 (-0.99, -0.32)
Quebec -0.50 (-0.78, -0.22) -0.54 (-0.88, -0.20)
Ontario -0.39 (-0.61, -0.16) -0.35 (-0.62, -0.08)
West -0.24 (-0.47, -0.00) -0.45 (-0.73, -0.16)
Age at baseline (Reference = 75+)
25–34 1.97 (0.23, 3.71) 1.55 (1.10, 2.00)
35–44 2.13 (1.59, 2.68) 1.19 (0.76, 1.63)
45–54 1.64 (1.34, 1.94) 0.75 (0.40, 1.10)
55–64 1.11 (0.88, 1.35) 0.76 (0.43, 1.09)
65–74 0.69 (0.46, 0.92) 0.41 (0.09, 0.73)
Annual Household Income (Reference = < $20,000)
$21,000–$40,000 0.13 (-0.07, 0.33) 0.28 (-0.04, 0.60)
$41,000–$60,000 0.08 (-0.16, 0.32) 0.44 (0.10, 0.78)
$61,000–$80,000 0.44 (0.13, 0.74) 0.36 (-0.01, 0.74)
> $80,000 0.18 (-0.12, 0.48) 0.65 (0.27, 1.02)
Education (Reference = University degree(s))
< High school diploma 0.31 (0.06, 0.55) 0.12 (-0.14, 0.39)
High school or Trade school diploma 0.25 (0.02, 0.48) 0.32 (0.07, 0.56)
Some University, or University certificate/
diploma
0.36 (0.08, 0.64) 0.10 (-0.20, 0.40)
Average level of pain, past week (reference = no 
pain) 
Mild to moderate, prevents no activities 0.19 (0.01, 0.37) 0.11 (-0.11, 0.33)
Moderate, prevents a few activities 0.08 (-0.12, 0.28) -0.12 (-0.40, 0.16)
Moderate to severe, prevents some activities 0.34 (0.06, 0.63) 0.02 (-0.39, 0.43)
Severe pain that prevents most activities 0.00 (-0.66, 0.67) 0.04 (-0.76, 0.85)
Smoking status (reference = quit smoking)
Current smoker -0.49 (-0.74, -0.24) -0.18 (-0.46, 0.09)
Never smoked -0.12 (-0.27; 0.04) -0.01 (-0.21, 0.19)
Number of live births -0.02 (-0.06, 0.02) n/a
Alcohol/week (Reference = None)
1 to 6 (WOMEN) or 1 to 13 (MEN) 0.06 (-0.10, 0.21) -0.09 (-0.30, 0.13)
7 or more (WOMEN) or 14 or more (MEN) -0.16 (-0.39, 0.07) -0.25 (-0.55, 0.05)
Menopausal status (reference = menopaused at 
baseline)
Not menopaused -0.16 (-0.50, 0.17) n/a
Menopaused in the past 5 years -0.15 (-0.49, 0.20)
Change, participation in regular activity (reference = 
did not, do now)
Did not, and do not now (no, no) 0.28 (0.05, 0.52) 0.42 (0.12, 0.71)
Did, but do not anymore (yes, no) 0.28 (0.04, 0.53) 0.27 (-0.04, 0.58)
Did and still do (yes, yes) 0.24 (0.01, 0.47) 0.17 (-0.11, 0.45)
Change, number of sedentary hours (reference = 
high to low)
Low to high 0.32 (0.09, 0.56) 0.52 (0.22, 0.83)
High at baseline, stayed high 0.13 (-0.08, 0.33) 0.23 (-0.03, 0.49)
Low at baseline, stayed low 0.17 (-0.04, 0.38) 0.38 (0.13, 0.64)Page 8 of 11
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improved)
Decline in how happy they usually feel -0.37 (-0.65, -0.10) -0.33 (-0.66, 0.01)
Feel about the same -0.23 (-0.44, -0.02) -0.09 (-0.35, 0.17)
Perception of general health (reference = poor, and 
stayed that way)
High, dropped to poor 0.38 (0.15, 0.60) 0.13 (-0.17, 0.43)
Poor, went to high 0.02 (-0.22, 0.27) 0.29 (0.04, 0.53)
Perception of health stayed high 0.12 (-0.06, 0.31) 0.11 (-0.12, 0.33)
The first eight variables are based on baseline data; the remaining 5 represent change between baseline and the 5-year follow-up.
Table 5: Multivariable linear regression models for change in BMI for women and men (Continued)(6.8 pounds). Given the results in Figure 1, this suggests
that men under age 45 and women under age 55 may be
putting on approximately 0.45 kg or one pound per year,
which levels off in the middle-aged groups and begins to
reverse in the oldest age groups.
The regression models suggest that there are factors asso-
ciated with change in BMI, but much of the variance
remains unexplained, and the models must be interpreted
with caution due to the wide confidence intervals associ-
ated with many of the estimates. Nevertheless, the find-
ings tend to be consistent with previous research,
although there are some notable exceptions. For example,
several studies have noted an association between
increased weight and a variety of comorbid conditions
[3,11] as well as the number of comorbid conditions [11],
which was not observed in the current study. This could in
part be because comorbidities may have been less severe
than is typical for many diseases, as very sick subjects
tended not to participate or to drop out of the cohort.
Moreover, previously noted associations between
increased weight and lower income [10,22] were not
found. Activity restriction also had little effect, despite
previous research to the contrary [22], but that may be
because other variables such as change in sedentary hours
and change in participation in regular activity are also in
our models. Level of pain also produced little in the way
of interesting results, other than for women who noted
moderate to severe pain that prevented some activities.
Our data did suggest a moderate effect of region, with the
central region most likely to show an increase in BMI. One
previous Canadian study noted almost no effect of region
[22], but a study of region in the USA did note higher rates
of obesity in the South Central and Northeast Central
regions as compared to New England, the Atlantic regions,
Mountain and Pacific regions [17]. Younger participants
gained more weight than older participants, and the
impact of menopause was small but in the expected direc-
tion [24], with more weight gain in those who were
already menopausal at baseline.
Current smokers had less gain than those who had never
smoked or had recently quit, particularly for women,
which is consistent with other research [5,22], while the
results for alcohol intake suggest that higher levels in
intake are associated with small declines in weight, which
differs from previous findings [22]. However, it should be
noted that alcohol consumption in this sample was rela-
tively low, with a median of 0.2 drinks per week for the
women and 2.0 per week for the men.
All education levels below the University level were asso-
ciated with more weight gain, which was more pro-
nounced for women and consistent with past findings
[5,10,18]. Number of children appeared to have little
effect on weight change for women, which has also been
noted by others [26], despite widely held beliefs to the
contrary [25,26]. However, this may be because many
respondents had their children long before the baseline
measurement, and parity may therefore have contributed
to baseline weight rather than change in weight.
The ability to assess the effect of behaviour change, and its
impact on change in weight, is one of the strengths of this
study. Compared to those who did not participate in
physical activity but do now, all other groups showed
small BMI gains, supporting other research that demon-
strated a healthy effect of increased activity on BMI
[10,29]. Moreover, compared to those who went from a
high to a low number of sedentary hours, the other groups
showed small gains in BMI. Those who indicated that
their level of happiness had declined or stayed the same
saw small decreases in BMI compared with those whose
level of happiness had improved. Finally, a decrease in
self-rated health, which has been associated with higher
BMI in other research [30], was associated with increased
BMI in women but not in men. For men, increase in BMI
tended to be associated with a perception of improved
general health.
One limitation to this study was the loss to follow-up, as
only 90.7% of the baseline sample could be included even
when using multiple imputation. Moreover, multiple
imputation also has assumptions and limitations. For
example, the technique assumes that the baseline data
were sufficiently detailed to predict year 5 weights, and
that, given the information available for predicting miss-Page 9 of 11
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baseline to those who did not participate [31]. It is possi-
ble that despite adjusting for baseline characteristics, the
non-respondents at year 5 were different from those with
complete data. However, inclusion of the imputed data
was considered to be preferable to simply basing all esti-
mates on those with complete data at both time points, as
at least some bias adjustment is preferable to none.
Caution must be used when interpreting any results based
on BMI data. While BMI is a commonly used indicator of
weight category, it is a composite measure that is unable
to distinguish between fat and lean tissue [20]. Moreover,
the BMI cut-points for overweight and obese subjects may
need to be adjusted for certain non-white people, as well
as the elderly [2,10]. Finally, waist circumference, which is
also an important indication for assessing obesity-related
health risk [2,10,32], was not measured in the CaMos
cohort.
Conclusion
This study provides evidence that Canadians have a higher
BMI than that which is currently recommended for opti-
mal health. Moreover, weight appears to be increasing in
younger age groups, although this reverses after age 65 in
both men and women. These findings suggest that a sub-
stantial number of people may be putting their health at
risk due to being overweight or obese. Although there is a
tendency to stay in the same weight category, this increase
in BMI over time underscores the need for public health
efforts aimed at combating the current epidemic of obes-
ity, especially in younger men and women.
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